Then a biopsy changed my life forever: I was diagnosed with stage 3 melanoma at 22 years old. And the scariest part of it all ...

The following is a summary of “Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: ...

Moderna’s move into personalised cancer therapy continues to proceed ... to Keytruda alone in patients with high-risk stage 3 or 4 melanoma who were given the therapy as an adjuvant treatment ...

Melanoma, a skin cancer with a high mutation rate ... another distinct antigen signature that differentiates between stage III melanoma patients who experienced recurrence and those who did ...

Amgen has announced top-line results of its phase 3 clinical trials that were evaluating the efficacy and safety of talimogene laherparapvec in for the treatment of unresected stage IIIB ...

In this study, a cancer array was used to analyze and ... distinct antigen signature that differentiates between stage III melanoma patients who experienced recurrence and those who did not." ...

Another Phase III study with Canvaxin in melanoma patients (stage IV; n = 496 ... Here we describe cancer vaccine candidates using MPL adjuvant in the most advanced stage of development.

King Charles has been told how advances in skin cancer treatment in Australia could help patients with other types of cancer.

Breast cancer treatment is rapidly evolving, with innovations in precision medicine, immunotherapy, and AI-driven diagnostics ...

Scientists found the compound, also known as vitamin K3, triggered some of the prostate cancer cells in mice to burst and die ...

Patients with low-count chronic lymphocytic leukemia phenotype monoclonal B-cell lymphocytosis had a 1.86-fold greater risk ...

Melanoma, a skin cancer with a high mutation rate ... another distinct antigen signature that differentiates between stage III melanoma patients who experienced recurrence and those who did ...